Please login to the form below

Not currently logged in
Email:
Password:

NIHR appoints Simon Denegri to lead public engagement in research

Former AMRC CEO joins as national director for public participation and engagement in research

The UK's National Institute for Health Research (NIHR) has appointed Simon Denegri as the Institute's national director for public participation and engagement in research.

In his new position Denegri will be tasked with encouraging more people to take part in health and social care research in the UK.

This will include giving patients the right information and support to be able to talk to NHS staff about ongoing research into their condition.

Denegri, who is also currently chair of the NIHR's Involve programme, will work closely with NHS organisations, Public Health England, Healthwatch, patient groups and other stakeholders in this new role.

His previous roles include serving as CEO of Ovarian Cancer Action for six months during 2011 and CEO of the Association of Medical Research Charities (AMRC) from 2006 until 2011.

Prior to his role at the AMRC, Denegri was director of corporate communications at the Royal College of Physicians of London from 2003.

23rd March 2012

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Aurora

Aurora is a multi-award winning healthcare marketing communications agency delivering proven results for clients...

Latest intelligence

Mapping content strategies to pharma lifecycle management
In these tough economic times, we should be ramping up our pharma lifecycle management (LCM) strategies. These are well-established strategies for managing and extending the commercial value of products. So...
Back from the future – innovation for pharma
After 5 days of seeing amazing innovations, having discussions about the future of medicine and the practicalities of living on Mars. Plus listening to inspiring speakers from fighter plane-flying physicians...
Cost containment and the German market
The healthcare system’s budget limitations will face further pressure from challenges such as personalised medicine...

Infographics